Could a diabetes and cholesterol drug combo regrow hair?

NCT ID NCT07696585

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial tests whether a custom cream containing metformin (a diabetes drug), simvastatin (a cholesterol drug), and betamethasone (a steroid) can regrow hair in people with patchy alopecia areata, an autoimmune condition causing hair loss. Participants apply the cream twice daily for 12 weeks. The study measures hair regrowth using a standard scalp scoring system. It aims to find a safer, more effective topical option for those who haven't responded to or are dissatisfied with current treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
topical cream containing metformin 30%, simvastatin 2%, and betamethasone valerate 0.1%
What this could lead to
If successful, this could offer a new, safe, and effective topical treatment option for people with patchy alopecia areata, potentially reducing the need for systemic therapies.
What could go wrong
This is an early-stage trial with a small number of participants (60). The combination cream may cause skin irritation or allergic reactions, and its effectiveness compared to existing treatments is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.